Editorial: Special issue on modeling schizophrenia

Behavioural Brain Research

Volumn 204, Issue 2, 2009, Pages 255-257

  Feldon, J ^a   Weiner, I ^b  

^a SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

BEHAVIOR DISORDER; BRAIN DAMAGE; COGNITIVE DEFECT; DISEASE COURSE; DISEASE MODEL; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG RESEARCH; EDITORIAL; GENE INTERACTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; LOCOMOTION; MENTAL STRESS; NEGATIVE SYNDROME; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROCHEMISTRY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; POSITIVE SYNDROME; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; WORKING MEMORY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; PHENOTYPE; SCHIZOPHRENIA;

EID: 69249205390     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.07.013     Document Type: Editorial

References (14)

1. Desbonnet L., Waddington J.L., Colm M.P., and O'Tuathaigh C.M. Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes?. Behav Brain Res 204 (2009) 258-273
2. Ayhana Y., Sawa A., Ross C.A., and Pletnikov M.V. Animal models of gene-environment interactions in schizophrenia. Behav Brain Res 204 (2009) 274-281
3. Powell S.B., Zhoua X., and Geyer M.A. Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res 204 (2009) 282-294
4. Tseng K.Y., Chambers R.A., and Lipska B.K. The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behav Brain Res 204 (2009) 295-305
5. Lodge D.J., and Grace A.A. Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia. Behav Brain Res 204 (2009) 306-312
6. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204 (2009) 313-321
7. Meyer U., and Feldon J. Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res 204 (2009) 322-334
8. Barak S. Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome. Behav Brain Res 204 (2009) 335-351
9. Bickel S., and Javitt D.C. Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behav Brain Res 204 (2009) 352-362
10. Berretta S., Gisabella B., and Benes F.M. A rodent model of schizophrenia derived from postmortem studies. Behav Brain Res 204 (2009) 363-368
11. Weiner I., and Arad M. Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behav Brain Res 204 (2009) 369-386
12. Yee B.K., and Feldon J. Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction. Behav Brain Res 204 (2009) 387-395
13. Floresco S.B., Zhang Y., and Enomot T. Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav Brain Res 204 (2009) 396-409
14. Seillier A., and Giuffrida A. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Behav Brain Res 204 (2009) 410-415